Clorox Co-The

Clorox launches allergen‑neutralizing PURE™ sprays to tap growing indoor‑wellness trend, while a cloud‑based ERP upgrade targets cost cuts and margin recovery.

Clorox’s dividend allure clashes with earnings uncertainty as its ERP overhaul seeks to boost efficiency amid sector pressure.

Clorox Co. offers steady dividends but faces margin pressure, regulatory hurdles, and a growing shift toward green cleaning—can its brand adapt to win new markets?

Clorox shares steady in the mid‑hundreds, reflecting a solid consumer‑staples position but flat earnings; investors see limited upside without strategic shifts.

Clorox stock dips modestly to $101.32 on Dec 10, 2025, holding a 16.1x P/E and $12B market cap amid commodity pressures, sustainability pushes, and a stable consumer staples outlook.

Clorox Co. released its un-audited earnings presentation and press release for the fiscal quarter and half-year ending September 30, 2025, but the lack of detailed financial metrics limits the ability to assess the company’s current financial trajec…

The Clorox Company’s recent stock surge is driven by both momentum and underlying stability, but a closer look at its fundamentals, regulatory landscape, and competitive positioning reveals nuanced risks and opportunities that may impact its valuati…

Clorox’s stock price has seen modest growth, but a 10-year investment would have yielded a meager 5.6% return, raising concerns about the company’s lackluster performance and transparency.

The Clorox Company has demonstrated resilience in a competitive market, with a moderate stock price increase and a substantial market value of 14.58 billion USD.

As of the latest available data, Clorox’s stock price has fluctuated between $117.35 and $171.37 over the past year, closing at $120.31.